Phuturdex › Diseases › Nasopharyngeal disease
Drugs in development · updated 30 October 2026
Nasopharyngeal disease: drugs in development
As of 30 October 2026 there are 1 active clinical trials (recruiting or ongoing, phases I–III) on 3 drugs for nasopharyngeal disease. 0 are experimental, that is not yet approved in the United States.
Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.
Sign in free →Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| CisplatinCis Platinum, Cisplatine | III | 1 | NCT03840421 |
| Fluorouracil5-Fluorouracil, Adrucil | III | 1 | NCT03840421 |
| GemcitabineGemcitabin, Gemzar | III | 1 | NCT03840421 |
Sorted by most advanced phase and number of active trials.
All 3 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Nasopharyngeal Carcinoma 71 drugs
- Nasopharyngeal neoplasm 32 drugs
- Head and neck squamous cell carcinoma 321 drugs
- Metastasis 493 drugs
- Carcinoma 137 drugs
- Non-small-cell lung carcinoma 726 drugs
- Laryngeal neoplasm 35 drugs
- Mouth Neoplasms 49 drugs
- Hypopharyngeal Neoplasms 33 drugs
- Epstein–Barr virus infection 30 drugs
- Ovarian neoplasm 411 drugs
- Head and neck neoplasms 184 drugs
Broader categories
- Neoplasm 671 drugs
- Carcinoma 137 drugs
- Glandular and epithelial neoplasm 12 drugs
- Otorhinolaryngologic disease 4 drugs
- Pharyngeal Neoplasms 5 drugs
- Stomatognathic disease 4 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D009302 “Nasopharyngeal Diseases”.